| Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center |
NCT00806754: Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490) |
|
|
| Completed | 4 | 340 | US | Ciclesonide nasal spray + placebo Azelastine, Ciclesonide nasal spray + Azelastine | AstraZeneca | Rhinitis, Allergic, Perennial | 05/07 | 08/07 | | |
NCT00404547: Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102) |
|
|
| Completed | 4 | 1121 | Canada | Ciclesonide, Usual Care Inhaled Glucocorticosteroids | AstraZeneca | Asthma | 04/08 | 12/08 | | |
NCT00458835: Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422) |
|
|
| Completed | 4 | 30 | US | Ciclesonide | Covis Pharma S.à.r.l. | Allergic Rhinitis | 04/08 | 04/08 | | |
| Completed | 4 | 72 | NA | Ciclesonide | Cantonal Hosptal, Baselland | Asthma, Bronchial | 08/08 | 08/08 | | |
NCT00793858: A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray |
|
|
| Withdrawn | 4 | 0 | US | placebo, isotonic ciclesonide, hypotonic ciclesonide | University of Chicago, Sunovion | Allergic Rhinitis | 09/09 | | | |
NCT00826969: Ciclesonide for the Treatment of Airway Hyperresponsiveness |
|
|
| Completed | 4 | 64 | Europe | Ciclesonide, Placebo | AstraZeneca | Asthma | 07/10 | 10/11 | | |
NCT01333800: Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric Asthma |
|
|
| Completed | 4 | 94 | RoW | Beclomethasone, Ciclesonide | Grünenthal Colombiana S.A. | Asthma | 12/10 | 12/10 | | |
| Completed | 4 | 349 | RoW | Ciclesonide, Omnaris, Levocetirizine, XYZAL, Ciclesonide & Levocetirizine, Omnaris nasal spray | Handok Inc., Takeda | Allergic Rhinitis | 07/12 | 07/12 | | |
NCT01654536: A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) |
|
|
| Completed | 4 | 737 | US | ciclesonide nasal aerosol, Zetonna, ciclesonide nasal spray, Omnaris | Sunovion | Perennial Allergic Rhinitis | 07/13 | 07/13 | | |
| Completed | 4 | 30 | Europe | Ciclesonide, Alvesco, Placebo | University of Nottingham, Nottingham University Hospitals NHS Trust, University Hospitals, Leicester | Asthma | 10/13 | 12/13 | | |
NCT01550471: Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis |
|
|
| Completed | 4 | 22 | US | Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo, Ciclesonide, Beclomethasone, Placebo, Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase, Ciclesonide, Placebo, Beclomethasone, QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo, Beclomethasone, Ciclesonide, Placebo, QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris, Beclomethasone, Placebo, Ciclesonide, Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase, Placebo, Ciclesonide, Beclomethasone, Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris, Placebo, Beclomethasone, Ciclesonide | West Penn Allegheny Health System | Asthma, Allergic Rhinitis | 08/15 | 08/15 | | |
| Terminated | 4 | 6 | Canada | inhaled corticosteroid, Flovent; Pulmicort; Alvesco. | University of Alberta, GlaxoSmithKline | Asthma | 10/15 | 10/15 | | |
2006-002450-30: An Open label Study to Compare Systemic Side Effects of High Dose Fluticasone/Salmeterol with that of High Dose Ciclesonide /Salmeterol in Symptomatic Asthmatics |
|
|
| Ongoing | 4 | 20 | Europe | Alvesco 160 inhaler, Flixotide Accuhaler, Alvesco 160 inhaler, Flixotide Accuhaler | Hull and East Yorkshire Hospitals Trust | Chronic asthma | | | | |
| | 4 | 40 | Europe | Ciclesonide, Fluticasone Proprionate, Ciclesonide (Alvesco), Fluticasone Proprionate, Ciclesonide (Alvesco), Fluticasone Proprionate | Bispebjerg University Hospital, Bispebjerg Hospital | Asthma | | 03/15 | | |
NCT03141424: Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma |
|
|
| Recruiting | 4 | 110 | Europe | Tapering of inhaled corticosteroid (ICS) treatment, budesonide, fluticasone proprionate, mometasone furoate, beclometasone dipropionate, ciclesonide | Hvidovre University Hospital | Asthma | 06/24 | 06/24 | | |
